SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

03 Aug 2024 Evaluate
Revenue reduced marginally to stand at Rs. 226.06 millions during the quarter ended June 2024. The figure stood at Rs. 229.35 millions during the year-ago period.Net profit showed a marginal rise at Rs. 25.32 millions for the quarter ended June 2024, as compared to corresponding quarter of last year.Operating Profit saw a handsome growth to 43.08 millions from 41.45 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 226.06 229.35 -1.43 226.06 229.35 -1.43 956.40 957.49 -0.11
Other Income 0.74 0.12 516.67 0.74 0.12 516.67 2.42 2.38 1.68
PBIDT 43.08 41.45 3.93 43.08 41.45 3.93 230.60 184.45 25.02
Interest 0.20 0.16 25.00 0.20 0.16 25.00 1.07 1.33 -19.55
PBDT 42.88 41.29 3.85 42.88 41.29 3.85 229.53 183.12 25.34
Depreciation 9.04 8.31 8.78 9.04 8.31 8.78 34.36 32.33 6.28
PBT 33.84 32.98 2.61 33.84 32.98 2.61 195.17 150.79 29.43
TAX 8.52 8.30 2.65 8.52 8.30 2.65 50.16 37.45 33.94
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.40 -0.50 -180.00
PAT 25.32 24.68 2.59 25.32 24.68 2.59 145.01 113.34 27.94
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 123.05 0.00
PBIDTM(%) 19.06 18.07 5.45 19.06 18.07 5.45 24.11 19.26 25.16
Peers
Company Name CMP
Sun Pharma Inds. 1692.90
Dr. Reddys Lab 1220.70
Cipla 1229.70
Zydus Lifesciences 938.90
Lupin 2319.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×